Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
about
Intraocular and serum cytokine profiles in patients with intermediate uveitisTargeting interleukin-6 for noninfectious uveitisInterleukin-6 blockade in ocular inflammatory diseasesRoles of interleukin-17 in uveitisAdministration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice.Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome.Small heat shock protein αA-crystallin prevents photoreceptor degeneration in experimental autoimmune uveitis.Fms-like tyrosine kinase 3 ligand decreases T helper type 17 cells and suppressors of cytokine signaling proteins in the lung of house dust mite-sensitized and -challenged mice.Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis.Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.Emerging role of antioxidants in the protection of uveitis complications.Interleukin-17 in various ocular surface inflammatory diseasesIL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.Cytokines in autoimmune uveitis.Expression of IL-8, IL-6 and IL-1β in tears as a main characteristic of the immune response in human microbial keratitis.Understanding autoimmunity in the eye: from animal models to novel therapies.miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease.Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosisBirdshot uveitis: current and emerging treatment optionsThe future of uveitis treatmentPro-inflammatory and anti-angiogenic effects of bisphosphonates on human cultured retinal pigment epithelial cells.Cutting-edge issues in autoimmune uveitis.IL-6/IL-6 receptor system and its role in physiological and pathological conditions.Immunotherapeutic implication of IL-6 blockade.A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells.From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.Application of multiplex immunoassay technology to investigations of ocular disease.Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.IL-6 blockade in the management of non-infectious uveitis.Pharmacologic Treatment of Noninfectious Uveitis.CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection.Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.The Role of Th17 Cells in the Pathogenesis of Behcet's DiseaseExpression Analysis of Cytokine and Chemokine Genes during the Natural Course of Murine Experimental Autoimmune Uveoretinitis.Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
P2860
Q24619574-BD32E181-3B77-40C7-80E8-4DE632E1DC2EQ26782493-1221D03A-5207-4EEF-B91E-7BD28BBA21D7Q27011357-D671438E-4330-4155-BD44-5F1D46EC7713Q28079126-F58D3640-E99F-473B-958B-3E574C5FE542Q30913978-F31B83AA-81E8-4AF1-85C5-FF5415E167C9Q33517638-34389F40-163C-41B7-8765-8FC15E44C110Q33595169-268FAA3C-B197-4780-BFB2-BB2CAD8B3F55Q34221494-20BE6EDD-6DB5-4089-B7DC-35CBD50B650FQ34268977-AAEC2656-2186-438F-9BE2-3EB01B7F90E7Q34358363-36C7C8DB-9BAE-4FF0-9304-1421883E90BAQ34692643-55BAD82D-56F3-49FB-8D5A-32C0F9B2B0F7Q34887046-4F8B1C89-879F-47C2-8B38-D2CF5F1ED7AFQ35072565-E57157F7-A6A2-48EB-9C41-EEA119B2352DQ35269684-2C23043A-6919-454C-94F5-EB8470F47110Q35294461-F7FBCF68-6B8D-41EE-B401-99C175EAC087Q35380605-E2180411-048E-4B29-B561-96A03CAE2CACQ36069594-F606A1D3-E0E7-415E-BAD6-98B5B7121454Q36512305-D56A3E05-F42D-4F31-98E5-21E507481F5BQ36956399-4A95C6BE-9877-4A09-ADB1-D0531364900BQ37412317-1006BDDD-9C4D-4629-B75E-09C6F07CBC4EQ37554382-F05107FD-FF54-4116-81E3-A4EE377EE4C6Q37626356-39265DD3-C7B5-4F69-B739-EC13DE593391Q37931096-0A6129AD-E3F8-4F5D-88A9-56B3E7C64A7AQ37949664-A87DDB72-4DA6-432B-8A03-2772D17D164BQ37965754-738AA582-90F7-43C6-9A8B-4616F103FC36Q38250103-49A9CA50-6423-4A11-A11F-AF6CCF8B8D84Q38333473-CA3EC429-3EDB-4392-BBB7-BF6C9681A493Q38336406-0EBB868D-7D9E-4ACA-9FAB-28218732AD1CQ38941639-00848C4D-D337-4F37-9FD7-F3EAC6E385CAQ39890245-2ADBCB50-F0FC-4F37-B932-FAC12F9B763FQ40045785-038B0FB1-353A-40FD-82B3-254E09EFC8E7Q40094684-218EDC62-4770-4B84-95C0-4D41414DB946Q40204739-2BB3870A-B8CA-4B7D-89C9-350BB9A08F22Q40450258-9535E98A-5BED-4080-B582-B2BAFD138CCFQ40473896-B990A233-D759-4840-A4E1-EEA7CF8BE3D8Q40889756-16C59CA1-3A4E-4640-93FD-9E7D3C6C4066Q41117094-AA0EECFF-F8CA-4BD7-9CBB-23F994F50F73Q41161415-C6DCBBC9-09C3-454A-9FDB-31278590F3FEQ41787579-54CA6A90-508B-4EBE-B732-F0AF4A882332Q41954592-D6952525-776A-4CE4-92C2-67C6B6353926
P2860
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
@en
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
@nl
type
label
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
@en
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
@nl
prefLabel
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
@en
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
@nl
P2093
P2860
P356
P1433
P1476
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
@en
P2093
Akihiko Yoshimura
Daniel J Cua
Hiroki Yoshida
Koh-Hei Sonoda
Nobuyuki Ohguro
Takashi Kobayashi
Takeru Yoshimura
Tatsuro Ishibashi
Yoshiyuki Ohsugi
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEN489
P577
2009-01-22T00:00:00Z